Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;36(1):1-12.
doi: 10.1007/s11011-020-00623-1. Epub 2020 Sep 29.

Linking chronic kidney disease and Parkinson's disease: a literature review

Affiliations
Review

Linking chronic kidney disease and Parkinson's disease: a literature review

Jesús D Meléndez-Flores et al. Metab Brain Dis. 2021 Jan.

Abstract

Chronic kidney disease (CKD) has been typically implicated in cardiovascular risk, considering the function the kidney has related to blood pressure, vitamin D, red blood cell metabolism, and electrolyte and acid-base regulation. However, neurological consequences are also attributed to this disease. Among these, recent large epidemiological studies have demonstrated an increased risk for Parkinson's disease (PD) in patients with CKD. Multiple studies have evaluated individually the association of blood pressure, vitamin D, and red blood cell dysmetabolism with PD, however, no study has reviewed the potential mechanisms related to these components in context of CKD and PD. In this review, we explored the association of CKD and PD and linked the components of the former to propose potential pathways explaining a future increased risk for PD, where renin-angiotensin system, oxidative stress, and inflammation have a main role. Potential preventive and therapeutic interventions based on these associations are also explored. More preclinical studies are needed to confirm the potential link of CKD conditions and future PD risk, whereas more interventional studies targeting this association are warranted to confirm their potential benefit in PD.

Keywords: Anemia; Chronic kidney disease; Oxidative stress; Parkinson’s disease; Renin-angiotensin system.

PubMed Disclaimer

References

    1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG (2003) Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115:291–297 - PubMed
    1. Annuk M, Fellström B, Akerblom O et al (2001) Oxidative stress markers in pre-uremic patients. Clin Nephrol 56(4):308–314 - PubMed
    1. Arnold R, Issar T, Krishnan AV, Pussell BA (2016) Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis 5:2048004016677687 - PubMed - PMC
    1. Asahina M, Vichayanrat E, Low DA et al (2013) Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry 84(6):674–680 - PubMed
    1. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FWK, Chapman RS, Maxwell PH, Choi P (2009) Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 75(9):976–981 - PubMed

MeSH terms

LinkOut - more resources